维普中文期刊产品整合服务
32篇 您的检索式:作者名="Friedman AM"
    题名 作者 年代 出处 被引量
1重组脊髓灰质炎病毒用于治疗复发胶质母细胞瘤(英文)显示文摘Background The prognosis of patients with recurrent World Health Organization(WHO)grade IV malignant glioma is dismal,and there is currently no effective therapy.We conducted a dose-finding and toxicity study in this population of patients,evaluating convection-enhanced,intratumoral delivery of the recombinant nonpathogenic polio-rhinovirus chimera(PVSRIPO).PVSRIPO recognizes the poliovirus receptor CD155,which is widely expressed in neoplastic cells of solid tumors and in major components of the tumor microenvironment.Methods We enrolled consecutive adult patients who had recurrent supratentorial WHO grade IV malignant glioma,confirmed on histopathological testing,with measurable disease(contrast-enhancing tumor of≥1 cm and≤5.5 cm in the greatest dimension).The study evaluated seven doses,ranging between 107 and 1010 50%tissue-culture infectious doses(TCID50),first in a dose-escalation phase and then in a dose-expansion phase.Results From May 2012 through May 2017,a total of 61 patients were enrolled and received a dose of PVSRIPO.Dose level-1(5.0×107TCID50)was identified as the phase 2 dose.One dose-limiting toxic effect was observed;a patient in whom dose level 5(1010TCID50)was administered had a grade 4 intracranial hemorrhage immediately after the catheter was removed.To mitigate locoregional inflammation of the infused tumor with prolonged glucocorticoid use,dose level 5 was deescalated to reach the phase 2 dose.In the dose-expansion phase,19%of the patients had a PVSRIPO-related adverse event of grade 3 or higher.Overall survival among the patients who received PVSRIPO reached a plateau of 21%(95%confidence interval,11 to 33)at 24 months that was sustained at 36 months.Conclusions Intratumoral infusion of PVSRIPO in patients with recurrent WHO grade IV malignant glioma confirmed the absence of neurovirulent potential.The survival rate among patients who receivedPVSRIPO immunotherapy was higher at 24 and 36 months than the rate among historical controls.Desjardins A Gromeier M Herndon JE 2nd Beaubier N Bolognesi DP Friedman AH Friedman HS McSherry F Muscat AM Nair S Peters KB Randazzo D Sampson JH Vlahovic G Harrison WT McLendon RE Ashley D Bigner DD 2018中华神经外科疾病研究杂志2018,17,4:2
2Prediction and prevention of ischemie placental disease显示文摘Friedman AM Cleary KL 2014Semin Perinatol2014,38,3:1
3Atypical complications encountered with epicardial electrophysiological procedm'es 显示文摘Killu AM Friedman PA Mulpuru SK et at 2013Heart Rhythm2013,10,:1
4Prediction and prevention of ischemic placental disease显示文摘Friedman AM Cleary KL 2014Semin Perinatol2014,38,3:1
5Ocular blood flow velocity in age-related macular degeneration显示文摘Friedman E Krupsky S Lane AM 1995Ophthalmology1995,102,4:1
6Preoperative screening of contact lens wearers before refractive surgery显示文摘Budak K Hamed AM Friedman NJ 1999J Refract Surg1999,25,8:1
7Predictors and outcomes of 'super-response' to cardiac resynchronization therapy显示文摘Killu AM Grupper A Friedman PA 2014J Card Fail2014,20,6:1
8Predictors and outcomes of 'super-response' to cardiac resynchronization therapy 显示文摘Killu AM Grupper A Friedman PA 2014J Card Fail2014,20,6:1
9Global right atrial mapping of human atrial flutter:the presence of posteromedial(sinus venosa region)functional block and double potentials显示文摘Friedman PA Luria D Fenton AM 2001Circulation2001,101,:1
10Prediction and prevention of ischemic placental disease显示文摘Friedman AM Cleary KL 2014Semin Perinatol2014,58,3:1
11Predictors and outcomes of ' superre- sponse' to cardiac resynchronization therapy 显示文摘Killu AM Grupper A Friedman PA 2014J Card Fail2014,20,:1
12Outcomes of cardiac resynchronization therapy in the elderly显示文摘Killu AM Wu JH Friedman PA 0,,:1
13Reasons for intracranial hypertension and hemodynamic instability during acute elevations of intra-abdominal pressure: observations in a large animal model显示文摘Rosenthal RJ Friedman RL Kahn AM 1998J Gastrointest Surg1998,2,5:1
14Core mechanisms in ‘ theory of mind’显示文摘Leslie AM Friedman O German TP 2004Trends Cogn Sci2004,8,12:1
15Age and experience- related improvements in gap detection in the rat显示文摘Friedman JT Peiffer AM Clark MG 2004Brain Res Dev Brain Res2004,152,:1
16Prediction and prevention of ischemic placental disease显示文摘Friedman AM Cleary KL 2014Semin Perinatol2014,38,3:1
17Dinueleotide repeats in the human surfaetant protein B gene and respiratory distress syndrome 显示文摘Floros J Veletza SV Kotikalapudi P Krizkova L Karinch AM Friedman C 1995Biochem J1995,305,2:1
18Identification of a myeloid-derived suppressor cell cystatin-like protein that inhibits metastasis显示文摘Boutté AM Angela M Friedman David B Bogyo Matthew 2011Faseb J2011,25,8:1
19Effect of amniotic fluid on cationic lipid mediated transfection and viral infection显示文摘Douar AM Themis M Friedman T 1996Gene Therap1996,3,:1
20Prediction and prevention of ischemic placental disease显示文摘Friedman AM Cleary KL Semin Perinatol0,38,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费